News
DSNKY
16.44
-0.96%
-0.16
Weekly Report: what happened at DSNKY last week (1005-1009)?
Weekly Report · 2d ago
Weekly Report: what happened at DSNKY last week (0928-1002)?
Weekly Report · 10/05 09:20
AstraZeneca, Daiichi Sankyo Expand Cancer Push Through Summit Partnership
Benzinga · 10/02 13:28
AstraZeneca, Daiichi Sankyo collaborate with Summit Therapeutics to evaluate Datroway-ivonescimab combo
Seeking Alpha · 10/02 06:55
Summit Therapeutics, AstraZeneca And Daiichi Sankyo Announce Clinical Trial Collaboration To Evaluate Ivonescimab With TROP2-Directed ADC Datroway Across Multiple Tumor Types, Starting With Phase III First-Line Triple-Negative Breast Cancer Study
Benzinga · 10/02 06:36
Weekly Report: what happened at DSNKY last week (0921-0925)?
Weekly Report · 09/28 09:19
Merck pulls BLA for antibody-drug conjugate I-DXd for small cell lung cancer
Seeking Alpha · 09/25 21:07
Merck, Daiichi Sankyo Withdraw Application for Accelerated Approval of Lung Cancer Treatment
Dow Jones · 09/25 21:03
Weekly Report: what happened at DSNKY last week (0914-0918)?
Weekly Report · 09/21 09:19
Merck, Astra, Roche and Corcept among winners of EU drug recommendations this week
Seeking Alpha · 09/18 13:50
Astra-Daiichi breast cancer drug Enhertu recommended for NHS use in England
Seeking Alpha · 09/17 13:23
AstraZeneca, Daiichi Drug Has Good Lung-Cancer Data, But Competition Awaits -- Market Talk
Dow Jones · 09/14 14:50
Weekly Report: what happened at DSNKY last week (0907-0911)?
Weekly Report · 09/14 09:20
Reported Earlier, AstraZeneca And Daiichi Sankyo's Enhertu Cuts Risk Of Disease Progression Or Death By 37.0% Versus Pembrolizumab Plus Chemotherapy In Phase III Trial
Benzinga · 09/14 05:32
Weekly Report: what happened at DSNKY last week (0831-0904)?
Weekly Report · 09/07 09:18
Astra, Daiichi granted EU nod for Enhertu in first-line breast cancer
Seeking Alpha · 09/01 16:15
Weekly Report: what happened at DSNKY last week (0824-0828)?
Weekly Report · 08/31 09:20
Weekly Report: what happened at DSNKY last week (0817-0821)?
Weekly Report · 08/24 09:20
Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance
Seeking Alpha · 08/20 12:00
Weekly Report: what happened at DSNKY last week (0810-0814)?
Weekly Report · 08/17 09:20
More
Webull provides a variety of real-time DSNKY stock news. You can receive the latest news about Daiichi Sankyo through multiple platforms. This information may help you make smarter investment decisions.
About DSNKY
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.